A theme quietly building in 2026:
INR weakness + Yuan appreciation + Import Substitution.
The Chinese Yuan has appreciated nearly 20% against the INR over the last year, creating a reasonably meaningful shift in competitiveness if it sustains.
The market seems to be noticing.
The Nifty India Manufacturing Index is outperforming Nifty this year by a wide margin.
The logic is straightforward:
• A weaker rupee makes Indian exports more competitive globally. • A stronger yuan makes Chinese imports relatively more expensive. • Domestic manufacturers gain from import substitution. • Earnings often follow currency-driven competitiveness with a lag.
We've seen similar setups in previous cycles where currencies did the heavy lifting before profits and stock prices caught up.
Could manufacturing—particularly exporters and import-substitution beneficiaries—turn out to be this cycle's biggest surprise?
#Manufacturing #India #MakeInIndia #Investing #Markets #Exports
Ukraine has released the full video of Operation Spiderweb the daring container hidden drone operation which left over 40 Russian airforce aircraft damaged or destroyed last year.
if you're under 50 and you stay healthy, i think you will live to 150 years old minimum
the medical singularity is happening.
just in the past 2 months alone:
> revmed's pancreatic cancer drug (daraxonrasib) doubled survival in the deadliest cancer there is, 13.2 months vs 6.7 on chemo. it got a standing ovation from 40k+ doctors at the world's biggest cancer conference
> a one-time gene editing infusion (verve-102) permanently switched off the gene that drives bad cholesterol and cut it up to 62% from a single dose. one and done, no daily pill for life
> a lung cancer pill (lorlatinib) kept 60% of patients with spread cancer progression-free at 5 years. the longest anyone has ever held back a metastatic solid tumor with a single drug
> mayo built an ai that catches pancreatic cancer on routine ct scans up to 3 years before doctors can. it spotted 73% of the earliest cases vs 39% for human radiologists
> lilly's new weight loss drug (retatrutide) hit up to 30% body weight loss in its big phase 3 trial, and along the way it cut knee arthritis pain by 76% and dropped bad cholesterol about 20%
and we are still just at the beginning of the exponential
call me crazy but i'm a believer when Demis hassabis says we will cure all disease in the next 10 years